IL96249A - Injectable solution containing a bis-indole alkaloid complex, and a process for its preparation - Google Patents

Injectable solution containing a bis-indole alkaloid complex, and a process for its preparation

Info

Publication number
IL96249A
IL96249A IL9624990A IL9624990A IL96249A IL 96249 A IL96249 A IL 96249A IL 9624990 A IL9624990 A IL 9624990A IL 9624990 A IL9624990 A IL 9624990A IL 96249 A IL96249 A IL 96249A
Authority
IL
Israel
Prior art keywords
months
zinc
aqueous solution
vinblastine
bis
Prior art date
Application number
IL9624990A
Other languages
English (en)
Hebrew (he)
Other versions
IL96249A0 (en
Original Assignee
Vegyeszeti Richter Gideo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vegyeszeti Richter Gideo filed Critical Vegyeszeti Richter Gideo
Publication of IL96249A0 publication Critical patent/IL96249A0/xx
Publication of IL96249A publication Critical patent/IL96249A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Press Drives And Press Lines (AREA)
  • Press-Shaping Or Shaping Using Conveyers (AREA)
  • Powder Metallurgy (AREA)
IL9624990A 1989-11-07 1990-11-06 Injectable solution containing a bis-indole alkaloid complex, and a process for its preparation IL96249A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU895804A HU204995B (en) 1989-11-07 1989-11-07 Process for producing pharmaceutical composition comprising alkaloid with bis-indole skeleton, with antitumour activity and suitable fr parenteral purposes

Publications (2)

Publication Number Publication Date
IL96249A0 IL96249A0 (en) 1991-08-16
IL96249A true IL96249A (en) 1995-07-31

Family

ID=10970758

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9624990A IL96249A (en) 1989-11-07 1990-11-06 Injectable solution containing a bis-indole alkaloid complex, and a process for its preparation

Country Status (37)

Country Link
US (1) US5397784A (ru)
JP (1) JP3042702B2 (ru)
KR (1) KR0164601B1 (ru)
CN (1) CN1053569C (ru)
AR (1) AR245592A1 (ru)
AT (1) AT401469B (ru)
AU (1) AU638504B2 (ru)
BE (1) BE1004051A4 (ru)
BG (1) BG60609B1 (ru)
CA (1) CA2029368C (ru)
CH (1) CH682130A5 (ru)
CZ (1) CZ279433B6 (ru)
DE (1) DE4035253B4 (ru)
DK (1) DK266390A (ru)
ES (1) ES2026062A6 (ru)
FI (1) FI100455B (ru)
FR (1) FR2653998B1 (ru)
GB (1) GB2238241B (ru)
GR (1) GR1001041B (ru)
HU (1) HU204995B (ru)
IE (1) IE62387B1 (ru)
IL (1) IL96249A (ru)
IT (1) IT1242724B (ru)
LT (1) LT3334B (ru)
LV (1) LV10687B (ru)
MY (1) MY104595A (ru)
NL (1) NL9002412A (ru)
NO (1) NO175565C (ru)
NZ (1) NZ236005A (ru)
PL (1) PL164881B1 (ru)
PT (1) PT95810B (ru)
RU (1) RU1828401C (ru)
SE (1) SE509715C2 (ru)
SK (1) SK278421B6 (ru)
UA (1) UA13162A (ru)
YU (1) YU48373B (ru)
ZA (1) ZA908855B (ru)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2385528C (en) 1999-10-01 2013-12-10 Immunogen, Inc. Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
JP2002100303A (ja) * 2000-09-20 2002-04-05 Hitachi Ltd カラ−陰極線管
US20050170015A1 (en) * 2000-10-31 2005-08-04 Brown Dennis M. Antiproliferative colchicine compositions and uses thereof
US20110015221A1 (en) * 2003-12-23 2011-01-20 Pierre Fabre Medicament Pharmaceutical composition of vinflunine which is intended for parenteral administration preparation method thereof and use of same
FR2863891B1 (fr) * 2003-12-23 2006-03-24 Pf Medicament Composition pharmaceutique de vinflunine destinee a une administration parentale, procede de preparation et utilisation
US8512761B2 (en) * 2006-01-27 2013-08-20 Yale University Fast acting inhibitor of gastric acid secretion
TWI678213B (zh) * 2015-07-22 2019-12-01 美商史倍壯製藥公司 用於長春新鹼硫酸鹽脂質體注射之即可使用的調配物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD155034A1 (de) * 1980-07-31 1982-05-12 Uwe Olthoff Verfahren zur herstellung stabiler kalziumhaltiger injektionsloesungen
IT1170152B (it) 1982-07-19 1987-06-03 Lilly Co Eli Miglioramenti a o riguardanti formulazioni di vinca-alcaloidi
US4619935A (en) * 1983-03-17 1986-10-28 Eli Lilly And Company Stable oncolytic formulations
HU195513B (en) * 1984-10-16 1988-05-30 Richter Gedeon Vegyeszet Process for producing stable solutions of alkaloides with bis-indole skeleton
FR2597750B1 (fr) * 1986-04-25 1989-06-02 Pf Medicament Solution aqueuse stable de sulfate de vincristine
IL83086A (en) * 1987-07-06 1991-03-10 Teva Pharma Stable,injectable solutions of vincristine salts
US4923876A (en) * 1988-04-18 1990-05-08 Cetus Corporation Vinca alkaloid pharmaceutical compositions

Also Published As

Publication number Publication date
NL9002412A (nl) 1991-06-03
BE1004051A4 (fr) 1992-09-15
PL164881B1 (en) 1994-10-31
DK266390A (da) 1991-05-08
GB2238241A (en) 1991-05-29
SE9003523D0 (sv) 1990-11-06
JP3042702B2 (ja) 2000-05-22
CH682130A5 (ru) 1993-07-30
FI100455B (fi) 1997-12-15
RU1828401C (ru) 1993-07-15
ATA223090A (de) 1996-02-15
FR2653998A1 (fr) 1991-05-10
IT1242724B (it) 1994-05-17
DK266390D0 (da) 1990-11-06
IL96249A0 (en) 1991-08-16
SK540290A3 (en) 1997-05-07
GB9024222D0 (en) 1990-12-19
UA13162A (uk) 1997-02-28
LV10687A (lv) 1995-06-20
CZ279433B6 (cs) 1995-04-12
SK278421B6 (en) 1997-05-07
SE509715C2 (sv) 1999-03-01
YU209590A (sh) 1993-05-28
CA2029368A1 (en) 1991-05-08
ES2026062A6 (es) 1992-04-01
MY104595A (en) 1994-04-30
DE4035253A1 (de) 1991-05-08
HU204995B (en) 1992-03-30
NO904821D0 (no) 1990-11-06
US5397784A (en) 1995-03-14
NZ236005A (en) 1992-03-26
PT95810B (pt) 1997-11-28
CZ540290A3 (en) 1994-11-16
IE62387B1 (en) 1995-01-25
ZA908855B (en) 1991-08-28
HU895804D0 (en) 1990-01-28
IT9067868A1 (it) 1992-05-06
NO175565B (no) 1994-07-25
HUT55225A (en) 1991-05-28
PT95810A (pt) 1991-09-13
LTIP512A (en) 1994-11-25
KR0164601B1 (ko) 1999-01-15
GB2238241B (en) 1993-10-06
KR910009245A (ko) 1991-06-28
AR245592A1 (es) 1994-02-28
FR2653998B1 (fr) 1995-02-17
IT9067868A0 (it) 1990-11-06
IE903993A1 (en) 1991-05-08
CA2029368C (en) 2000-01-04
GR900100795A (en) 1992-04-17
BG60609B1 (bg) 1995-10-31
FI905508A0 (fi) 1990-11-07
NO175565C (no) 1994-11-02
SE9003523L (sv) 1991-05-08
GR1001041B (el) 1993-03-31
LT3334B (en) 1995-07-25
DE4035253B4 (de) 2004-10-07
LV10687B (en) 1995-12-20
CN1053185A (zh) 1991-07-24
AT401469B (de) 1996-09-25
CN1053569C (zh) 2000-06-21
YU48373B (sh) 1998-07-10
NO904821L (no) 1991-05-08
AU6584590A (en) 1991-05-16
AU638504B2 (en) 1993-07-01
JPH03206040A (ja) 1991-09-09

Similar Documents

Publication Publication Date Title
US5397784A (en) Stable parenteral compositions of vinblastine or vincristine
US4780465A (en) Aqueous solution containing a quinolone carboxylic acid
HU195513B (en) Process for producing stable solutions of alkaloides with bis-indole skeleton
US4406888A (en) Aqueous micellar solutions of levonantradol and N-methyllevonantradol and lyophilic forms thereof for reconstitution
JPH0647536B2 (ja) トコフエロ−ル類含有液剤
AU613810B2 (en) Cisplatin hypertonic solution
HU211477A9 (hu) Bisz-indol-alkaloid-sót tartalmazó injekciós oldat
KR102427941B1 (ko) 이부프로펜 및 아르기닌을 함유하는 안정성이 개선된 주사용 제제
SI9012095A (sl) Injekcijska raztopina in postopek za njeno pridobivanje
JPH08245382A (ja) 点眼液
EP0486854A1 (en) Aqueous compositions containing calcitonin for the nasal administration
JPH06211659A (ja) 点鼻薬組成物
GB2143435A (en) Copper heptonate complexes for treating trace element deficiency
AU1134500A (en) 'Soluble 2-chloro-2'-deoxyadenosine formulations'

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed